Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Spur Therapeutics Presents Updated Phase 1/2 Data on Its Gene Therapy Candidate in Gaucher Disease at ESGCT 32nd Annual Congress
-
Unaudited Interim Results for the six months ended 31 July 2025
-
Equinor ASA: Share buy-back – third tranche for 2025
-
Operational update
-
Operational update
-
Shell third quarter 2025 update note
-
Edf: EDF announces the final results of its tender offer for two series of outstanding hybrid notes
-
NBPE - Transaction in Own Shares
-
Transaction in own shares
-
Progress on share buyback programme
-
Sampo plc’s share buybacks 6 October 2025
-
Scottish Rite for Children Ranked No. 1 for Pediatric Orthopedic Care by U.S. News & World Report
-
Scottish Rite for Children Ranked No. 1 for Pediatric Orthopedic Care by U.S. News & World Report
-
TextMagic group’s sales results for Q3 2025
-
Weekly progress on share repurchase program to cover share plans and reduce capital
-
Himax Technologies, Inc. Schedules Third Quarter 2025 Financial Results Conference Call on Thursday, November 6, 2025, at 8:00 AM EST
-
Navatar Brings AI-Powered Private Credit CRM on Salesforce Amid $30 Trillion Market Boom
-
Passengers Are Already Digital. This Is a Big Opportunity for Aviation
-
Linamar Corporation to Acquire George Fischer’s Leipzig Facility
-
Start of Day Message
-
Arcadis reports transactions under its current share buyback program
-
PT Danantara Investment Management Invites the Selection of a Prequalified Vendor List of Prospective Partners for Waste-to-Energy Projects
-
Children’s National ranked top hospital in the nation by U.S. News & World Report
-
Children’s National ranked top hospital in the nation by U.S. News & World Report
-
WatchGuard’s Next-Gen Firebox Rackmounts Deliver Scalable, Integrated Security for MSPs and Growing Networks
-
Brookfield Raises $20 billion for Record Transition Fund
-
Brookfield Raises $20 billion for Record Transition Fund
-
From Data to Dialogue: Singapore PR Professionals Explore AI's Role in Next-Gen Communications at IPRS - Notified Panel Discussion
-
From Data to Dialogue: Singapore PR Professionals Explore AI's Role in Next-Gen Communications at IPRS - Notified Panel Discussion
-
Privé Jets Announces Launch of Jet Card Membership Program
-
20-Year-Old Founder Behind Avalon Capital Investment Sets Sights on Building a Next-Generation Multi-Strategy Firm
-
School Nutrition Leaders Tour Tollcrest Dairy in Wheatland to Strengthen Food and Agriculture Literacy
-
Consumer Guardian Group Announces Expanded Legal Services for Timeshare Owners Facing Financial Strain
-
CORRECTION - Verde AgriTech Announces District Scale High-Grade Magnetic Rare Earths Discovery in Minas Gerais, Brazil
-
Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
-
New Miami Wellness Startup Makes CEOs Earn Their Seat—Starting With a 90-Minute Trek Through the Woods
-
Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
-
AEG Signs First-Of-Its-Kind Renewable Energy Agreement To Power UK Venues
-
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition
-
Interfor to Announce Third Quarter Results on November 6, 2025
-
THE CHAMPIONS COLLECTIVE DEBUTS THE FLORIDA PANTHERS’ 2025 STANLEY CUP CHAMPIONSHIP RING
-
Bombardier Completes Redemption for All of its 7.125% Senior Notes due 2026 and Partial Redemption for US$83,711,000 of its 7.875% Senior Notes due 2027
-
Park Aerospace Corp. Announces Date of Second Quarter Earnings Release and Conference Call
-
Parler Cloud Technologies and Kyvo Launch Global “Invite & Earn” Program — Rewarding Users and Their Referrals with 500 OPT Tokens Each
-
Parler Cloud Technologies and Kyvo Launch Global “Invite & Earn” Program — Rewarding Users and Their Referrals with 500 OPT Tokens Each
-
SPX Technologies to Report Third Quarter 2025 Financial Results
-
Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
-
Billor Establishes New Headquarters in Raleigh, North Carolina
-
PrairieSky Royalty Announces Conference Call for Q3 2025 Results
-
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

